Group 1 - The company has established a remote diagnostic network covering over 2,700 hospitals nationwide, leveraging the "China Digital Pathology Remote Diagnosis and Quality Control Platform" from the National Health Commission [2][3] - The company has accumulated over 2 million typical case digital pathology slice data [2][3] - The company is collaborating with domestic enterprises to develop a "Pathology Auxiliary Diagnosis System" aimed at addressing the shortage of pathology doctors and limited diagnostic experience in grassroots hospitals [2][3]